Lectures and seminars Welcome to join Virtual US Research Funding Seminar!

03-12-2020 12:00 pm - 1:00 pm Add to iCal
via Zoom

From this session, you will receive the understanding of US research funding mechanism primarily focused on Congressionally Directed Medical Research Programs (CDMRP) and some US Private Foundations, new funding opportunities and current KI awardee experiences-sharing!

US National Institute of Allergy and Infectious Diseases (NIAID) has gotten $1.5 billion in COVID-19 funding, making it the leading recipient of the money that Congress has given to NIH in three pandemic-related spending bills, much of it designated for research into treatments, vaccines, and diagnostics. The next two largest chunks went to the NIH director’s office ($1 billion) and NIH’s biomedical engineering institute ($500 million) to develop diagnostic tests, such as the rapid, point-of-care assays being developed through the Rapid Acceleration of Diagnostics, a Shark Tank–like competition. US Funding is not only about COVID-19.

Do you also want to receive some US funding?

From this session, you will receive the understanding of US research funding mechanism primarily focused on Congressionally Directed Medical Research Programs (CDMRP) and some US Private Foundations, new funding opportunities and current KI awardee experiences-sharing!

Time: 2020 December 3 (Thursday) 12.00-13.00 by ZOOM.
The following Prime awardees will share his/her tips and available for Q&A session afterwards.

Samir EL Andaloussi (CDMRP/Prime) - Muscle-Targeted Cell-Penetrating Peptides for Delivery of Cas9-RNPs and Modified mRNA to Dystrophic Muscle
Karin Loré (Gates Foundation/Prime)

  • Immunogenicity study of CureVac’s mRNA vaccine for Covid-19 in rhesus macaques
  • COVID-19: NHP Study of Novavax nanoparticle at Karolinska

More info about US Research Funding at KI.

Please have your registration by sending an email to Christine.chang@ki.se in order to receive your ZOOM link.

Contact